BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 30926428)

  • 21. Progesterone receptor (PR) isoforms PRA and PRB differentially regulate expression of the breast cancer resistance protein in human placental choriocarcinoma BeWo cells.
    Wang H; Lee EW; Zhou L; Leung PC; Ross DD; Unadkat JD; Mao Q
    Mol Pharmacol; 2008 Mar; 73(3):845-54. PubMed ID: 18042733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progesterone receptor isoforms and proliferation in the rat mammary gland during development.
    Kariagina A; Aupperlee MD; Haslam SZ
    Endocrinology; 2007 Jun; 148(6):2723-36. PubMed ID: 17332059
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PRB inhibited cell proliferation through let-7b-E2F1 in breast cancer.
    Asavasupreechar T; Saito-Koyama R; Miki Y; Tamai K; Abe J; Inoue C; Sato I; Boonyaratanakornkit V; Sasano H
    Endocr Relat Cancer; 2023 Jul; 30(7):. PubMed ID: 37130271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of progesterone receptor A and B isoforms in low-grade endometrial stromal sarcoma.
    Balleine RL; Earls PJ; Webster LR; Mote PA; deFazio A; Harnett PR; Clarke CL
    Int J Gynecol Pathol; 2004 Apr; 23(2):138-44. PubMed ID: 15084842
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progesterone receptor A predominance is a discriminator of benefit from endocrine therapy in the ATAC trial.
    Mote PA; Gompel A; Howe C; Hilton HN; Sestak I; Cuzick J; Dowsett M; Hugol D; Forgez P; Byth K; Graham JD; Clarke CL
    Breast Cancer Res Treat; 2015 Jun; 151(2):309-18. PubMed ID: 25917868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heterogeneity of progesterone receptors A and B expression in human endometrial glands and stroma.
    Mote PA; Balleine RL; McGowan EM; Clarke CL
    Hum Reprod; 2000 Aug; 15 Suppl 3():48-56. PubMed ID: 11041221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of initial subcellular localization of progesterone receptor on import kinetics and transcriptional activity.
    Li H; Fidler ML; Lim CS
    Mol Pharm; 2005; 2(6):509-18. PubMed ID: 16323958
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Developmental and hormonal regulation of progesterone receptor A-form expression in female mouse lung in vivo: interaction with glucocorticoid receptors.
    Shao R; Egecioglu E; Weijdegård B; Ljungström K; Ling C; Fernandez-Rodriguez J; Billig H
    J Endocrinol; 2006 Sep; 190(3):857-70. PubMed ID: 17003286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Progesterone action in human tissues: regulation by progesterone receptor (PR) isoform expression, nuclear positioning and coregulator expression.
    Scarpin KM; Graham JD; Mote PA; Clarke CL
    Nucl Recept Signal; 2009 Dec; 7():e009. PubMed ID: 20087430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Colocalization of progesterone receptors A and B by dual immunofluorescent histochemistry in human endometrium during the menstrual cycle.
    Mote PA; Balleine RL; McGowan EM; Clarke CL
    J Clin Endocrinol Metab; 1999 Aug; 84(8):2963-71. PubMed ID: 10443705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progesterone-induced inhibition of growth and differential regulation of gene expression in PRA- and/or PRB-expressing endometrial cancer cell lines.
    Smid-Koopman E; Kuhne LC; Hanekamp EE; Gielen SC; De Ruiter PE; Grootegoed JA; Helmerhorst TJ; Burger CW; Brinkmann AO; Huikeshoven FJ; Blok LJ
    J Soc Gynecol Investig; 2005 May; 12(4):285-92. PubMed ID: 15866122
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progestin and antiprogestin responsiveness in breast cancer is driven by the PRA/PRB ratio via AIB1 or SMRT recruitment to the CCND1 and MYC promoters.
    Wargon V; Riggio M; Giulianelli S; Sequeira GR; Rojas P; May M; Polo ML; Gorostiaga MA; Jacobsen B; Molinolo A; Novaro V; Lanari C
    Int J Cancer; 2015 Jun; 136(11):2680-92. PubMed ID: 25363551
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Altered progesterone receptor isoform expression remodels progestin responsiveness of breast cancer cells.
    Graham JD; Yager ML; Hill HD; Byth K; O'Neill GM; Clarke CL
    Mol Endocrinol; 2005 Nov; 19(11):2713-35. PubMed ID: 15976005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progesterone receptor isoform identification and subcellular localization in endometrial cancer.
    Leslie KK; Stein MP; Kumar NS; Dai D; Stephens J; Wandinger-Ness A; Glueck DH
    Gynecol Oncol; 2005 Jan; 96(1):32-41. PubMed ID: 15589577
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isoform specificity of progesterone receptor antibodies.
    Fabris V; Abascal MF; Giulianelli S; May M; Sequeira GR; Jacobsen B; Lombès M; Han J; Tran L; Molinolo A; Lanari C
    J Pathol Clin Res; 2017 Oct; 3(4):227-233. PubMed ID: 29085663
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progestins reinitiate cell cycle progression in antiestrogen-arrested breast cancer cells through the B-isoform of progesterone receptor.
    McGowan EM; Russell AJ; Boonyaratanakornkit V; Saunders DN; Lehrbach GM; Sergio CM; Musgrove EA; Edwards DP; Sutherland RL
    Cancer Res; 2007 Sep; 67(18):8942-51. PubMed ID: 17875737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of progesterone receptors A and B in the mouse ovary during the estrous cycle.
    Gava N; Clarke CL; Byth K; Arnett-Mansfield RL; deFazio A
    Endocrinology; 2004 Jul; 145(7):3487-94. PubMed ID: 15044369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ulipristal Acetate Inhibits Progesterone Receptor Isoform A-Mediated Human Breast Cancer Proliferation and BCl2-L1 Expression.
    Esber N; Le Billan F; Resche-Rigon M; Loosfelt H; Lombès M; Chabbert-Buffet N
    PLoS One; 2015; 10(10):e0140795. PubMed ID: 26474308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estrogen receptor isoform-specific induction of progesterone receptors in human osteoblasts.
    Rickard DJ; Waters KM; Ruesink TJ; Khosla S; Katzenellenbogen JA; Katzenellenbogen BS; Riggs BL; Spelsberg TC
    J Bone Miner Res; 2002 Apr; 17(4):580-92. PubMed ID: 11918216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Progesterone receptor B gene inactivation and CpG hypermethylation in human uterine endometrial cancer.
    Sasaki M; Dharia A; Oh BR; Tanaka Y; Fujimoto S; Dahiya R
    Cancer Res; 2001 Jan; 61(1):97-102. PubMed ID: 11196205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.